← Leaderboards
Marilena D'aurelio
Weill Medical Coll Of Cornell Univ
$1,697,482
Attributed
$3,394,963
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $999.9K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,394,963 · 3
By mechanism
R01$2,712,725 · 1
R21$682,238 · 2
Top collaborators
- Qiuying Chen6 shared
- Giovanni Manfredi1 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Zachary Michael Grinspan$2,917,018
- Qiuying Chen$1,822,488
- Justine Lottermoser$75,958
Others in their field
Other Emerging Leaders on “Response”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$195,683,539
- Kimberly Smith · Ppd Development Lp$115,671,664
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$70,992,558
Research focus
ResponseDefectMuscular AtrophyPublishingSymptomsTissuesMitochondrial DiseasesMusclePathogenesisPlasmaMetabolicSkeletal MuscleTargeted TreatmentMetabolic DiseasesGeneticKnockout MiceMouse ModelGenetic DiseasesEffective TherapyOxidative PhosphorylationImpairmentPathway InteractionsAffectMetabolic Phenotype
Grant awards (7)
Targeting GDF15-GFRAL signaling in mitochondrial myopathies$216,113
R21 · FY2025 · AR · contact PI
Metabolic remodeling of skeletal muscle in mitochondrial myopathies$533,741
R01 · FY2024 · AR · contact PI
Metabolic remodeling of skeletal muscle in mitochondrial myopathies$550,248
R01 · FY2023 · AR · contact PI
Metabolic remodeling of skeletal muscle in mitochondrial myopathies$544,746
R01 · FY2022 · AR · contact PI
Metabolic remodeling of skeletal muscle in mitochondrial myopathies$533,742
R01 · FY2021 · AR · contact PI
Modulation of intermediate metabolism, a new therapeutic approach for mitochondrial encephalomyopathies$466,125
R21 · FY2021 · NS · contact PI
Metabolic remodeling of skeletal muscle in mitochondrial myopathies$550,248
R01 · FY2020 · AR · contact PI